Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
Sapoznik S, Ortenberg R, Galore-Haskel G, Kozlovski S, Levy D, Avivi C, Barshack I, Cohen CJ, Besser MJ, Schachter J, Markel G. Sapoznik S, et al. Among authors: markel g. Cancer Immunol Immunother. 2012 Oct;61(10):1833-47. doi: 10.1007/s00262-012-1245-1. Epub 2012 Mar 24. Cancer Immunol Immunother. 2012. PMID: 22441657 Free PMC article.
Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.
Sapoznik S, Hammer O, Ortenberg R, Besser MJ, Ben-Moshe T, Schachter J, Markel G. Sapoznik S, et al. Among authors: markel g. Clin Dev Immunol. 2012;2012:818214. doi: 10.1155/2012/818214. Epub 2012 Apr 23. Clin Dev Immunol. 2012. PMID: 22778766 Free PMC article. Review.
Adoptive T-cell transfer in melanoma.
Itzhaki O, Levy D, Zikich D, Treves AJ, Markel G, Schachter J, Besser MJ. Itzhaki O, et al. Among authors: markel g. Immunotherapy. 2013 Jan;5(1):79-90. doi: 10.2217/imt.12.143. Immunotherapy. 2013. PMID: 23256800 Review.
Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies.
Besser MJ, Shapira-Frommer R, Itzhaki O, Treves AJ, Zippel DB, Levy D, Kubi A, Shoshani N, Zikich D, Ohayon Y, Ohayon D, Shalmon B, Markel G, Yerushalmi R, Apter S, Ben-Nun A, Ben-Ami E, Shimoni A, Nagler A, Schachter J. Besser MJ, et al. Among authors: markel g. Clin Cancer Res. 2013 Sep 1;19(17):4792-800. doi: 10.1158/1078-0432.CCR-13-0380. Epub 2013 May 20. Clin Cancer Res. 2013. PMID: 23690483 Clinical Trial.
MicroRNAs in cancer: lessons from melanoma.
Greenberg E, Nemlich Y, Markel G. Greenberg E, et al. Among authors: markel g. Curr Pharm Des. 2014;20(33):5246-59. doi: 10.2174/1381612820666140128210105. Curr Pharm Des. 2014. PMID: 24479804 Review.
Adoptive Cell Therapy for Metastatic Melanoma.
Merhavi-Shoham E, Itzhaki O, Markel G, Schachter J, Besser MJ. Merhavi-Shoham E, et al. Among authors: markel g. Cancer J. 2017 Jan/Feb;23(1):48-53. doi: 10.1097/PPO.0000000000000240. Cancer J. 2017. PMID: 28114254 Review.
148 results